Application 078150
- Type
- ANDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 100MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 300MG | No | No |
| 003 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078150-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | ||
| A078150-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | ||
| A078150-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 301d65b070ca… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | A-S Medication Solutions | aa246838-609c-4254-a8ec-d6f463a17960 | 2025-10-16 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | efb86e22-5a84-4b33-aad0-71dd5a2c6c8f | 2025-10-13 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 1ead7343-ab25-41b5-af4f-f903470e1dd9 | 2025-10-10 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 781b0d62-a760-4371-8908-1f61329928a6 | 2025-10-10 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | STALLION LABORATORIES PRIVATE LIMITED | b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9 | 2025-10-03 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | American Health Packaging | bbfdedd7-2baf-4bc6-be59-548a5cf21752 | 2025-10-03 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | be9a572d-e98a-41c1-83c5-859d9176dd1c | 2025-10-03 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | eaf5e41e-8ed3-404e-84e0-392bebdbc0b7 | 2025-10-03 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | da8438e1-755b-4195-baa7-464f3d9ee5bd | 2025-10-01 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 8f982b95-4e84-4e0c-a543-747bc3dd7531 | 2025-09-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d0510d04-460c-47d1-be72-0ee32c4ac640 | 2025-09-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 344d67fa-092e-4e71-b96a-25c71bfa6bb1 | 2025-09-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | bc1316b6-1fc4-4990-95a8-489881772876 | 2025-09-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 3f2ba3d6-6086-eaf2-e063-6294a90a7642 | 2025-09-19 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| gabapentin | GABAPENTIN | Coupler LLC | 3eeda97d-c3cd-65cd-e063-6394a90aae8b | 2025-09-16 | Warnings, Adverse reactions | gabapentin GABAPENTIN |
| gabapentin | GABAPENTIN | Zydus Lifesciences Limited | 8c0eeefc-ef5b-49f4-8411-ddbae312ed05 | 2025-09-15 | gabapentin GABAPENTIN | |
| GABAPENTIN | GABAPENTIN | MARKSANS PHARMA LIMITED | 98bb408d-c402-4da6-8f9d-5de4833dedc4 | 2025-09-12 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Epic Pharma, LLC | d592d828-8df1-480d-b179-bb9260a9c824 | 2025-09-12 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 310ce005-5a24-489a-b23c-d42ab6a3bfed | 2025-09-08 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 3cfd04ab-e421-441f-a10e-e4dd1412974d | 2025-09-05 | Warnings, Adverse reactions | gabapentin GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0143-3991 | Gabapentin | Gabapentin | West-ward Pharmaceutical Corp | ANDA | Current |
| 0143-3993 | Gabapentin | Gabapentin | West-ward Pharmaceutical Corp | ANDA | Current |
| 0143-3994 | Gabapentin | Gabapentin | West-ward Pharmaceutical Corp | ANDA | Current |
| 0143-9992 | Gabapentin | Gabapentin | West-ward Pharmaceutical Corp | ANDA | Current |
| 0143-9993 | Gabapentin | Gabapentin | West-ward Pharmaceutical Corp | ANDA | Current |
| 0143-9994 | Gabapentin | Gabapentin | West-ward Pharmaceutical Corp | ANDA | Current |
| 59115-073 | Gabapentin | Gabapentin | Hikma Pharmaceutical | ANDA | Current |
| 59115-073 | Gabapentin | Gabapentin | Hikma Pharmaceutical | ANDA | Current |
| 59115-074 | Gabapentin | Gabapentin | Hikma Pharmaceutical | ANDA | Current |
| 59115-074 | Gabapentin | Gabapentin | Hikma Pharmaceutical | ANDA | Current |
| 59115-075 | Gabapentin | Gabapentin | Hikma Pharmaceutical | ANDA | Current |
| 59115-075 | Gabapentin | Gabapentin | Hikma Pharmaceutical | ANDA | Current |
| 66336-439 | Gabapentin | Gabapentin | Dispensing Solutions, Inc. | ANDA | Current |
| 66336-567 | Gabapentin | Gabapentin | Dispensing Solutions, Inc. | ANDA | Current |